麻黃鹼
參考文獻

↑  . emc.   [8 October 2020]. （原始内容存档于2021-05-09）.
↑  . emc. 11 March 2015  [2020-10-08]. （原始内容存档于24 October 2020）.
↑  . DailyMed. 16 April 2020  [8 October 2020]. （原始内容存档于2020-09-26）.
↑  . Electronic Code of Federal Regulations.   [2020-10-08]. （原始内容存档于2022-04-06）.
1 2 3 4 5 6 7 8 9  . DrugBank Online. 2016-04-29  [2024-07-14]. （原始内容存档于2024-09-14）.
1 2  Volpp M, Holzgrabe U. . Eur J Pharm Sci. January 2019, 127: 175–184. PMID 30391401. doi:10.1016/j.ejps.2018.10.027.
1 2  Schmidt S.  [A closer look at long-established drugs: enantioselective protein binding and stability studies] (学位论文). Universität Würzburg. 2023. doi:10.25972/opus-34594 （德语）.
1 2  Gad MZ, Azab SS, Khattab AR, Farag MA. . Food Funct. October 2021, 12 (20): 9563–9582. PMID 34533553. doi:10.1039/d1fo02093e.
1 2 3 4 5 6 7  Chua SS, Benrimoj SI, Triggs EJ. . Biopharm Drug Dispos. 1989, 10 (1): 1–14. PMID 2647163. doi:10.1002/bdd.2510100102.
1 2 3 4 5 6 7 8 9 10 11 12 13  . The American Society of Health-System Pharmacists.   [2017-09-08]. （原始内容存档于2017-09-09）.
↑  Briggs GG, Freeman RK, Yaffe SJ.  9th. Philadelphia: Lippincott Williams & Wilkins. 2011: 495. ISBN 9781608317080. （原始内容存档于2017-09-08）.
1 2  .   [2017-10-08]. （原始内容存档于2017-08-05）.
↑  . PubChem.   [2024-08-30]. （原始内容存档于2024-12-03）.
↑  Soni MG, Shelke K, Amin R, Talati. . Bagchi D, Preuss HG  (编).  2nd. Boca Raton, Florida: CRC Press. 2013: 692. ISBN 9781439854266. （原始内容存档于2017-09-08）.
↑  Fischer J, Ganellin CR. . John Wiley & Sons. 2006: 541. ISBN 9783527607495.
↑  World Health Organization. . Geneva: World Health Organization. 2021. hdl:10665/345533 . WHO/MHP/HPS/EML/2021.02.
↑  Abourashed EA, El-Alfy AT, Khan IA, Walker L. . Phytotherapy Research. August 2003, 17 (7): 703–712. PMID 12916063. S2CID 41083359. doi:10.1002/ptr.1337.
1 2  Butterworth IV JF, Mackey DC, Wasnick JD. .  7th. McGraw-Hill Education. 2022  [2024-09-18]. ISBN 978-1-260-47379-7. （原始内容存档于2024-12-05）.
1 2  Drew CD, Knight GT, Hughes DT, Bush M. . British Journal of Clinical Pharmacology. September 1978, 6 (3): 221–5. PMC 1429447 . PMID 687500. doi:10.1111/j.1365-2125.1978.tb04588.x.
↑  Buckey Jr JC. . Oxford University Press. 2006: 201. ISBN 978-0-1997-4790-0.
↑  Sanford CA, Jong EC. . Elsevier Health Sciences. 2008: 139. ISBN 978-1437710694.
↑  Higashida K, Yamada M, Shimohata T. . Neurology. 2021-04-13, 96 (15 Supplement)  [2024-09-18]. ISSN 0028-3878. S2CID 266124150. doi:10.1212/WNL.96.15_supplement.2928. （原始内容存档于2022-11-23）.
↑  Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ,  et al. . JAMA. March 2003, 289 (12): 1537–45. PMID 12672771. doi:10.1001/jama.289.12.1470.
↑  Dwyer JT, Allison DB, Coates PM. . Journal of the American Dietetic Association. May 2005, 105 (5 Suppl 1): S80–6  [2024-09-18]. PMID 15867902. doi:10.1016/j.jada.2005.02.028. （原始内容存档于2020-08-09）.
↑  Bray GA, Bouchard C. . CRC Press. 2004: 494–496. ISBN 978-0-8247-4773-2. （原始内容存档于2014-06-26）.
↑  Magkos F, Kavouras SA. . Sports Medicine. 2004, 34 (13): 871–89. PMID 15487903. S2CID 1966020. doi:10.2165/00007256-200434130-00002.
↑  Yoo HJ, Yoon HY, Yee J, Gwak HS. . Pharmaceuticals. November 2021, 14 (11): 1198. PMC 8618781 . PMID 34832979. doi:10.3390/ph14111198 .
1 2  . accessdata.fda.gov. Food and Drug Administration.   [2024-07-14]. （原始内容存档于2017-11-02）.
1 2 3 4  . DailyMed.   [2024-07-14]. （原始内容存档于2024-12-05）.
1 2  Mayne Pharma. Ephedrine sulfate injection DBL (Approved Product Information). Melbourne: Mayne Pharma; 2004
1 2  Palamar J. . Health Policy. January 2011, 99 (1): 1–9. PMID 20685002. doi:10.1016/j.healthpol.2010.07.007.
↑  Joint Formulary Committee. British National Formulary, 47th edition. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2004. ISBN 0-85369-587-3
↑  Alec K. Statler; Christopher V. Maani; Arpan Kohli. . StatPearls [Internet].   [2024-09-02]. （原始内容存档于2023-03-06）.
↑  Edinoff, Amber N.; Swinford, Connor R.  10 (4): 39576. 2022-011-03  [2024-09-02]. doi:10.52965/001c.39576. （原始内容存档于2024-07-23）.  已忽略文本“journalHealth Psychology Research” (帮助); 请检查|date=中的日期值 (帮助)
↑  . Merck Manuals. January 2010. （原始内容存档于2011-03-24）.
1 2 3  Docherty JR. . Br J Pharmacol. June 2008, 154 (3): 606–622. PMC 2439527 . PMID 18500382. doi:10.1038/bjp.2008.124.
↑  Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Schaneberg BT,  et al. . The Journal of Pharmacology and Experimental Therapeutics. July 2007, 322 (1): 214–221. PMID 17405867. S2CID 86429875. doi:10.1124/jpet.107.120709.
↑  Kobayashi S, Endou M, Sakuraya F, Matsuda N, Zhang XH, Azuma M,  et al. . Anesthesia and Analgesia. November 2003, 97 (5): 1239–1245. PMID 14570629. doi:10.1213/01.ANE.0000092917.96558.3C .
↑  Munhall AC, Johnson SW. . Brain Research. January 2006, 1069 (1): 96–103. PMID 16386715. S2CID 40626692. doi:10.1016/j.brainres.2005.11.044.
↑  .   [2015-10-19]. （原始内容存档于2015-10-23）.
↑  Schier JG, Traub SJ, Hoffman RS, Nelson LS. . Journal of Toxicology. Clinical Toxicology. 2003, 41 (6): 849–53. PMID 14677795. S2CID 23359388. doi:10.1081/clt-120025350.
↑  WADA. The World Anti-Doping Code, World Anti-Doping Agency, Montreal, Canada, 2010. url 的存檔，存档日期2013-09-11.
↑  Baselt R.  8th. Foster City, CA: Biomedical Publications. 2008: 542–544.
↑  Levy WO, Kalidas K. Miller NS , 编. . Academic Press. 26 February 2010: 307–308. ISBN 978-0-12-496736-6.
↑  Ford MD, Delaney KA, Ling LJ, Erickson T (编). . Philadelphia: WB Saunders. 2001. ISBN 0-7216-5485-1.
↑  Dikotter F, Laamann LP. . University of Chicago Press. 16 April 2004: 199. ISBN 978-0-226-14905-9.
↑  Lieberman HR. . Nutr Rev. April 2001, 59 (4): 91–102. PMID 11368507. doi:10.1111/j.1753-4887.2001.tb06995.x.
1 2  Magkos F, Kavouras SA. . Sports Med. 2004, 34 (13): 871–889. PMID 15487903. doi:10.2165/00007256-200434130-00002.
1 2  Graham TE. . Can J Appl Physiol. 2001,. 26 Suppl: S103–S119. PMID 11897887.
↑  Microsoft Word – RedListE2007.doc 的存檔，存档日期2008-02-27.
↑  . Health Canada. January 9, 2002  [July 7, 2009]. （原始内容存档于2007-02-06）.
↑  Laccourreye O, Werner A, Giroud JP, Couloigner V, Bonfils P, Bondon-Guitton E. . European Annals of Otorhinolaryngology, Head and Neck Diseases. February 2015, 132 (1): 31–4. PMID 25532441. doi:10.1016/j.anorl.2014.11.001 .
↑  Legislative Services Branch. . laws-lois.justice.gc.ca. 2021-03-18  [2021-07-30]. （原始内容存档于2021-07-30）.
↑  Federal Register: June 4, 1997 (Volume 62, Number 107): Dietary Supplements Containing Ephedrine Alkaloids; Proposed Rule
↑  Federal Register: April 3, 2000 (Volume 65, Number 64): Dietary Supplements Containing Ephedrine Alkaloids; Withdrawal in Part
↑  Federal Register: February 11, 2004 (Volume 69, Number 28): Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Final Rule
↑   (PDF).   [2010-07-01]. （原始内容 (PDF)存档于2011-07-10）. Defendants-appellants, 459 F.3d 1033 (10th Cir. 2006)
↑  Nutraceutical Corporation; Solaray, Inc. Plaintiffs-Appellees vs. Andrew Von Eschenbach, Acting Commissioner, US.. Food and Drug Administration; United States Food and Drug Administration; Michael O. Leavitt, Secretary of the Department of Health and Human Services; Department of Health and Human Services; United States of America, We find that the FDA correctly followed the congressional directive to analyze the risks and benefits of EDS in determining that there is no dosage level of EDS acceptable for the market. (United States Court of Appeals Tenth Circuit 2006-08-17).[]
↑  .   [2011-03-21]. （原始内容存档于2011-02-10）.
↑  .   [2009-04-18]. （原始内容存档于2009-06-28）.
↑  Verordnung zur Neuordnung der Verschreibungspflicht von Arzneimitteln (AMVVNV). 的存檔，存档日期2014-05-17. V. v. 21. Dezember 2005 BGBl. I S. 3632; Geltung ab 1. Januar 2006.
↑  Long C. . 2007-01-15  [2016-05-09]. （原始内容存档于2016-05-30）.
↑  Zhu, Binling; Conlan, Xavier. . Forensic Science International. July 2020, 312  [2024-09-02]. doi:10.1016/j.forsciint.2020.110326.
1 2  Hertweck C, Jarvis AP, Xiang L, Moore BS, Oldham NJ. . ChemBioChem. October 2001, 2 (10): 784–6. PMID 11948863. S2CID 28159196. doi:10.1002/1439-7633(20011001)2:10<784::AID-CBIC784>3.0.CO;2-K.
1 2  Grue-Sorensen G, Spenser ID. . Journal of the American Chemical Society. May 1, 1988, 110 (11): 3714–3715. ISSN 0002-7863. doi:10.1021/ja00219a086.
↑  Yamasaki K, Tamaki T, Uzawa S, Sankawa U, Shibata S. . Phytochemistry. 1973, 12 (12): 2877–2882. Bibcode:1973PChem..12.2877Y. doi:10.1016/0031-9422(73)80499-6.